newsfilter
← Latest News
PR Newswire·

Kuehn Law Encourages Investors of Viking Therapeutics, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating Viking Therapeutics, Inc. (NASDAQ: VKTX) for potential breaches of fiduciary duties by officers & directors.
  • The investigation focuses on alleged self-dealing activities by the company's leadership.
  • Shareholders may be eligible for damages & corporate governance reforms.
  • Long-term VKTX stockholders can contact Justin Kuehn, Esq. via email at [email protected] or call (833) 672-0814 for a free consultation.
  • Kuehn Law covers all case costs & does not charge investor clients.
  • Shareholders are urged to act immediately due to potential time limitations on enforcing rights.
  • Participation aims to support the integrity & fairness of financial markets.